Trials / Conditions / Laryngeal Neoplasms

Laryngeal Neoplasms

27 registered clinical trials studyying Laryngeal Neoplasms — 5 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC NCT07400094	National Medical Research Radiological Centre of the Ministry of Health of Russia	Phase 2
Not Yet Recruiting	DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Y NCT07440290	Cancer Research UK	Phase 2 / Phase 3
Not Yet Recruiting	Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngea NCT06554028	Henan Cancer Hospital	Phase 2
Recruiting	European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] NCT06137378	University of Leipzig	Phase 2
Completed	Feasibility Study CORPPS NCT05406024	University Hospital, Lille	—
Recruiting	DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Posi NCT05768178	Cancer Research UK	Phase 2 / Phase 3
Unknown	Patient Augmented Reality and Vibratory Array Otorhinolaryngology Procedures NCT06227039	University of Virginia	N/A
Unknown	Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinom NCT04995120	Fudan University	Phase 2
Unknown	IORT in Local Advanced Laryngocarcinoma NCT04278638	Tianjin First Central Hospital	N/A
Completed	A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery NCT03010813	Chinese University of Hong Kong	N/A
Unknown	A Multicenter, Randomized, Case-control Study of Unilateral vs Bilateral Neck Dissection for cN0 Supraglottic NCT03392220	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	N/A
Terminated	Investigation of Contralateral Arytenoid Sparing IMRT for T1a & T2a Larynx Cancer & Analysis of Post-treatment NCT02633540	Fox Chase Cancer Center	Phase 2
Completed	Irreversible Electroporation(IRE) For Unresectable Laryngeal Neoplasms NCT02430675	Fuda Cancer Hospital, Guangzhou	N/A
Completed	Characterization of the Autofluorescence of Healthy and Pathological Tissues of Vocal Cords NCT03585075	Centre Hospitalier Universitaire de Besancon	—
Unknown	KTP vs CO2 Laser for the Treatment of Laryngeal Carcinoma NCT02672904	Kaplan Medical Center	N/A
Completed	Surgical Treatment of Early Stage Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic As NCT01257633	Centre Hospitalier Universitaire de Nīmes	—
Terminated	Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer NCT01216020	Azienda USL 4 Prato	Phase 2
Terminated	Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract NCT00721539	Stanford University	N/A
Unknown	Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma NCT01171235	Southern Medical University, China	—
Completed	Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers NCT01104714	Centre Hospitalier Universitaire de Nīmes	—
Terminated	MRI Laryngeal Imaging With a Surface Coil NCT00965003	Stanford University	EARLY_Phase 1
Terminated	Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Inducti NCT00941135	Fundacion Miguel Servet	Phase 2
Completed	F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients NCT00721799	University of Iowa	Phase 2
Completed	The Objective is to Respond to Patients' Needs in the Field of Larynx Replacement NCT00576134	University Hospital, Strasbourg, France	Phase 1
Unknown	Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy NCT00396617	University Hospital, Strasbourg, France	Phase 1
Completed	Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal NCT00534729	King Faisal Specialist Hospital & Research Center	N/A
Completed	Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants NCT00127465	University of Plymouth	Phase 1 / Phase 2